2741-7 |
Pepsins |
CCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Pepsins [Enzymatic activity/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2741-7 |
|
|
|
|
Both |
|
|
|
0 |
Pepsins Ur-cCnc |
|
|
|
Y |
|
Catalytic Concentration; Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.68 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
0 |
27410-0 |
Spermatozoa.motile/Spermatozoa^24H post ejaculation |
NFr |
Semen |
Pt |
Qn |
|
|
ACTIVE |
Spermatozoa Motile/Spermatozoa in Semen --24 hours post ejaculation |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
FERT |
|
27410-0 |
|
|
|
|
Observation |
|
|
|
0 |
Sperm Motile 24h p ejac NFr Smn |
|
|
|
Y |
|
24h p ejac; After; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Mot; Number fraction; p ejac; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Motile; URO; Urology |
2.79 |
2 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
27411-8 |
Iron/Creatinine |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Iron/Creatinine [Mass Ratio] in Urine |
|
MIN |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
CHEM |
|
27411-8 |
|
|
|
|
Both |
|
|
|
0 |
Iron/Creat Ur |
|
|
|
Y |
|
Chemistry; CR; Crea; Creat; Fe; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn |
2.7 |
2 |
|
|
|
|
|
|
|
ug/g{creat} |
|
|
|
0 |
27412-6 |
Ephedrine+Pseudoephedrine |
MCnc |
Vitr fld |
Pt |
Qn |
|
|
ACTIVE |
ePHEDrine+Pseudoephedrine [Mass/volume] in Vitreous fluid |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
27412-6 |
|
|
|
|
Both |
|
|
|
0 |
Ephedrin+Pseudo Vitf-mCnc |
|
|
|
Y |
|
Cenafed; DRUG/TOXICOLOGY; Drugs; Ectasule; Ephedrin+Pseudo; Level; Mass concentration; Point in time; Pseudoephed; QNT; Quan; Quant; Quantitative; Random; Sudafed; VitF; Vitreous Fluid; Vitreous humor; Vitreous humour |
2.7 |
2 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
27413-4 |
Dextromethorphan |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Dextromethorphan [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
27413-4 |
|
|
|
|
Both |
|
|
|
0 |
D-methorphan SerPl-aCnc |
|
|
|
Y |
|
Arbitrary concentration; Dextro-methorphan; D-methorphan; DRUG/TOXICOLOGY; Drugs; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.69 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
27414-2 |
Fungus |
Prid |
Stool |
Pt |
Nom |
Culture |
|
ACTIVE |
Fungus identified in Stool by Culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
27414-2 |
|
Culture |
|
|
Both |
|
|
|
0 |
Fungus Stl Cult |
|
|
|
|
|
Bowel movement; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Fung; Fungal; Fungi; Gastro; Gastroenterology; GI; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Stl; Stool = Fecal |
2.78 |
2 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
27415-9 |
Interferon.gamma |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Interferon gamma [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
HEM/BC |
|
27415-9 |
|
|
|
|
Both |
|
|
|
0 |
IGNF SerPl-mCnc |
|
|
|
Y |
|
G-INF; HEMATOLOGY/CELL COUNTS; IFN; IGNF; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
27416-7 |
SCL-70 extractable nuclear Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
SCL-70 extractable nuclear Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
27416-7 |
|
|
|
|
Both |
|
|
|
0 |
ENA Scl70 Ab Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; anti-topo I; Arbitrary concentration; Autoantibodies; Autoantibody; DNA-Topoisomerase I; ENA; ENA Scl70; NA; Nuc; Point in time; QNT; Quan; Quant; Quantitative; Random; Scleroderma; Scleroderma ab; Serology; Serum; SR; Topo I; Topoisomerase I; UniversalLabOrders |
2.73 |
2 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
27417-5 |
Candida sp Ab.IgA |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Candida sp IgA Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
Index |
|
|
|
|
|
|
MICRO |
|
27417-5 |
|
IA |
|
|
Both |
|
|
|
0 |
Candida IgA Ser IA-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cand; Candidiasis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Monilia; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; SUDS; Thrush |
2.73 |
2 |
|
|
|
|
|
|
|
[arb'U]/mL;{Index_val} |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
27418-3 |
chlordiazePOXIDE |
MCnt |
Stool |
Pt |
Qn |
|
|
ACTIVE |
chlordiazePOXIDE [Mass/mass] in Stool |
|
MIN |
DefinitionDescription |
|
|
ng/g |
|
|
|
|
|
|
DRUG/TOX |
|
27418-3 |
|
|
|
|
Both |
|
|
|
0 |
Chlordiazep Stl-mCnt |
|
|
|
Y |
|
Bowel movement; Chlordiaz; Chlordiaze; Chlordiazep; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; Librium; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal |
2.7 |
2 |
|
|
|
|
|
|
|
ng/g |
|
|
|
0 |
27419-1 |
Sodium |
SRat |
Stool |
24H |
Qn |
|
|
ACTIVE |
Sodium [Moles/time] in 24 hour Stool |
|
MIN |
DefinitionDescription |
|
|
meq/24 H |
|
|
|
|
|
|
CHEM |
|
27419-1 |
|
|
|
|
Both |
|
|
|
0 |
Sodium 24h Stl-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Na; Na+; QNT; Quan; Quant; Quantitative; sRate; Stl; Stool = Fecal; Substance Rate |
2.73 |
2 |
|
|
|
|
|
|
|
mmol/(24.h) |
|
|
|
0 |
2742-5 |
Angiotensin converting enzyme |
CCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
arb U/L |
|
|
|
|
|
|
CHEM |
|
2742-5 |
|
|
|
|
Both |
|
|
|
0 |
ACE SerPl-cCnc |
|
|
|
Y |
|
ACE; AGT; Angio convert enzy; Angiotensin I converting enzyme; Carboxycathepsin; Catalytic Concentration; Chemistry; Dipeptidylcarboxypeptidase; Enz; Enzymes; Kininase II; Lung; PDPA; Peptidase P; Peptidyl dipeptidase A; Pl; Plasma; Plsm; Point in time; Proangiotensin; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
U/L |
|
|
|
250 |
27420-9 |
Phosphatidylglycerol |
ACnc |
Amnio fld |
Pt |
Qn |
|
|
DISCOURAGED |
Phosphatidylglycerol [Units/volume] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
27420-9 |
|
|
|
|
Both |
|
|
|
0 |
PG Amn-aCnc |
|
|
|
Y |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Arbitrary Concentration; Chemistry; Fetal lung maturity; PG; Phosphatidyl Glycerol; Phosphotidylglycerol; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.69 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
27421-7 |
C peptide^40M post XXX challenge |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
C peptide [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
|
MIN |
DefinitionDescription |
|
|
mg/mL |
|
|
|
|
|
|
CHAL |
|
27421-7 |
|
|
|
|
Observation |
|
|
|
0 |
C peptide 40M p chal SerPl-mCnc |
|
|
|
Y |
|
40M p chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2 |
|
|
|
|
|
|
|
mg/mL |
|
|
|
0 |
27422-5 |
Streptococcus pneumoniae 3 Ab.IgG^2nd specimen |
MCnc |
Ser |
Pt |
Qn |
IA |
|
DEPRECATED |
Deprecated Streptococcus pneumoniae 3 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
27422-5 |
|
IA |
|
|
Observation |
|
|
|
0 |
Deprecated S pneum3 IgG sp2 Ser IA-mCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum3; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS |
2.7 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
27423-3 |
1,4-Dioxane |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
1,4-Dioxane [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
27423-3 |
|
|
|
|
Both |
|
|
|
0 |
1,4Dioxane SerPl Ql |
|
|
|
|
|
1,4-Diethylene Dioxide; 1,4-Diethylene oxide; 1,4-Dioxacyclohexane; 1,4Dioxane; Diethylene ether; Dioxan; DRUG/TOXICOLOGY; Drugs; Glycol ethylene ether; i; Ordinal; p-dioxane; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tetrahydro-1,4-dioxin; Tetrahydro-p-dioxin |
2.56 |
2 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
27424-1 |
Deoxypyridinoline |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Deoxypyridinoline [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
27424-1 |
|
|
|
|
Both |
|
|
|
0 |
DPD Ur-sCnc |
|
|
|
Y |
|
Chemistry; DPD; Dpyr; Free lysly-pyridinoline; Level; Lysylpyridinoline; Point in time; Pyradinium collagen crosslinks; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.73 |
2 |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
27425-8 |
Streptococcus pneumoniae 14 Ab.IgG^2nd specimen |
MCnc |
Ser |
Pt |
Qn |
IA |
|
DEPRECATED |
Deprecated Streptococcus pneumoniae 14 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
27425-8 |
|
IA |
|
|
Observation |
|
|
|
0 |
Deprecated S pneum14 IgG sp2 Ser IA-mCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum14; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS |
2.7 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
27426-6 |
Trichinella sp Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Trichinella sp IgM Ab [Units/volume] in Serum by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
27426-6 |
|
IA |
|
|
Both |
|
|
|
0 |
Trichinella IgM Ser IA-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR; SUDS; Tric; Trich |
2.69 |
2 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
27427-4 |
Streptococcus pneumoniae Danish serotype 7F Ab.IgG^2nd specimen |
MCnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
27427-4 |
|
IA |
|
|
Both |
|
|
|
0 |
S pneum Da 7F IgG sp2 Ser IA-mCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 7F; S pneum Da 7F Ab; S pneum Da 7F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 51 |
2.73 |
2 |
|
|
|
|
|
|
|
ug/mL |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.; Updated the "51" in the Component, which represented the U.S. serotype number, to the corresponding Danish serotype number to align with the widely accepted Danish nomenclature for Streptococcus pneumoniae serotypes |
0 |
27428-2 |
Streptococcus pneumoniae 1 Ab.IgG^1st specimen |
MCnc |
Ser |
Pt |
Qn |
IA |
|
DEPRECATED |
Deprecated Streptococcus pneumoniae 1 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
27428-2 |
|
IA |
|
|
Observation |
|
|
|
0 |
Deprecated S pneum 1 IgG sp1 Ser IA-mCnc |
|
|
|
Y |
|
ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum 1; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS |
2.7 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
27429-0 |
Streptococcus pneumoniae 19 Ab.IgG^2nd specimen |
MCnc |
Ser |
Pt |
Qn |
IA |
|
DEPRECATED |
Deprecated Streptococcus pneumoniae 19 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
27429-0 |
|
IA |
|
|
Observation |
|
|
|
0 |
Deprecated S pneum19 IgG sp2 Ser IA-mCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum19; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; Streptococcus pneumoniae 19f; SUDS |
2.7 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
2743-3 |
pH |
LsCnc |
Amnio fld |
Pt |
SemiQn |
|
|
ACTIVE |
pH of Amniotic fluid |
|
MAJ |
DefinitionDescription |
|
|
pH |
|
|
|
|
|
|
CHEM |
|
2743-3 |
|
|
|
|
Both |
|
|
|
0 |
pH Amn |
|
|
|
|
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Chemistry; Log molar concentration; Point in time; Random; SmQn |
2.75 |
1 |
|
|
|
|
|
|
|
[pH] |
|
|
|
0 |
27430-8 |
Streptococcus pneumoniae 3 Ab.IgG^1st specimen |
MCnc |
Ser |
Pt |
Qn |
IA |
|
DEPRECATED |
Deprecated Streptococcus pneumoniae 3 IgG Ab [Mass/volume] in Serum by Immunoassay --1st specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
27430-8 |
|
IA |
|
|
Observation |
|
|
|
0 |
Deprecated S pneum3 IgG sp1 Ser IA-mCnc |
|
|
|
Y |
|
ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum3; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS |
2.7 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
27431-6 |
Streptococcus pneumoniae 1 Ab.IgG^2nd specimen |
MCnc |
Ser |
Pt |
Qn |
IA |
|
DEPRECATED |
Deprecated Streptococcus pneumoniae 1 IgG Ab [Mass/volume] in Serum by Immunoassay --2nd specimen |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
27431-6 |
|
IA |
|
|
Observation |
|
|
|
0 |
Deprecated S pneum 1 IgG sp2 Ser IA-mCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum 1; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS |
2.7 |
2 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |